Porphyria cutanea tarda
Fatal babesiosis in an asplenic patient
Deciphering the molecular basis of venous thromboembolism
Haemostasis and thrombosis in liver disease
Co-morbidities and quality of life in elderly persons with haemophilia
Ribosome-associated nucleophosmin 1
A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia
Myeloma cell-induced disruption of bone remodelling compartments leads to osteolytic lesions and generation of osteoclast-myeloma hybrid cells
Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma
The proteasome inhibitor CEP-18770 enhances the anti-myeloma activity of bortezomib and melphalan
Increased levels of tissue factor activity and procoagulant phospholipids during treatment of children with acute lymphoblastic leukaemia
Quantitative assessment of PTPN11 or RAS mutations at the neonatal period and during the clinical course in patients with juvenile myelomonocytic leukaemia
An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma
Pathogenesis of the erythroid failure in Diamond Blackfan anaemia
Incidence and reasons for late failure after allogeneic haematopoietic cell transplantation following BuCy2 in acute myeloid leukaemia
Platelets release novel thiol isomerase enzymes which are recruited to the cell surface following activation
Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpura
Successful correction of murine sickle cell disease with reduced stem cell requirements reinforced by fractionated marrow infusions
Frequency of altered monoclonal protein production at relapse of multiple myeloma
Clinical and laboratory phenotype associated with the aspirin-like defect
Clinical and laboratory phenotype associated with the aspirin-like defect – response to Dragani et al
Interferon as an alternative to purine analogues in the treatment of hairy cell leukaemia
Interferon as an alternative to purine analogues in the treatment of hairy cell leukaemia – response to Benz et al
Insight into the molecular pathogenesis of hairy cell leukaemia, hairy cell leukaemia variant and splenic marginal zone lymphoma, provided by the analysis of their IGH rearrangements and somatic hypermutation patterns